American Journal of Pharmacy Benefits

The American Journal of Pharmacy Benefits (AJPB) publishes peer-reviewed research examining the impact of formulary management programs on the utilization, cost, and quality of pharmacy services to help develop clinical strategies for the management of pharmacy benefits for large populations. To provide pharmacy and formulary decision makers with the information they need to improve the efficiency and health outcomes in managing pharmaceutical care.

The American Journal of Pharmacy Benefits (AJPB) publishes peer-reviewed research that examines the impact of formulary management strategies on the utilization, cost, and quality of pharmacy services. The Journal presents case studies, research, and evidence-based tools to help decision makers develop clinical strategies to manage pharmacy benefits for large populations. Areas of particular interest include utilization management strategies (ie, prior authorization, step therapy, generic substitution, etc), outcomes research on Medicare Part D, formulary development and implementation strategies, research on adherence and compliance, cost sharing strategies (ie, copays, coinsurance, CDHPs, HDHPs, etc), cost utility analyses, economic burden of disease, and comparative effectiveness analysis of drug therapies.

All original articles are subjected to rigorous peer review. Manuscripts are also evaluated to determine the real world relevance of the information they contain. In addition to original research, the journal publishes review articles, commentaries, brief reports, editorials, or letters to the editor. The American Journal of Pharmacy Benefits was founded in 2009 as a sister publication to The American Journal of Managed Care. The Journal is indexed in both EMBASE and Cumulative Index to Nursing and Allied Health Literature (CINAHL), and circulates to approximately 20,000 individuals with important decision-making responsibilities affecting the inclusion and tier placement of drugs on formularies.

As the official publication of The Pharmacy & Therapeutics Society, the Journal is distributed to the Society’s 5000 members, as well as medical directors, pharmacy directors, corporate benefits managers, and other healthcare professionals across these 6 market segments: 1) HMO/PPO/IHOs; 2) hospitals; 3) long-term care; 4) PBMs; 5) VA/gov’t; and 6) employers.